Antibiotic azithromycin is DROPPED from RECOVERY trial
A commonly prescribed antibiotic called azithromycin, which was being investigated as a potential treatment for Covid-19, has been found to have no meaningful benefit for hospitalised patients. The findings come from the RECOVERY trial led by the University of Oxford, which assesses the benefits of different drugs in more than 20,000 severe Covid-19 cases at 176 … Read more